JPH04312521A - Mousse-like lubricant - Google Patents
Mousse-like lubricantInfo
- Publication number
- JPH04312521A JPH04312521A JP7912091A JP7912091A JPH04312521A JP H04312521 A JPH04312521 A JP H04312521A JP 7912091 A JP7912091 A JP 7912091A JP 7912091 A JP7912091 A JP 7912091A JP H04312521 A JPH04312521 A JP H04312521A
- Authority
- JP
- Japan
- Prior art keywords
- lubricant
- polyacrylamide
- vitamin
- carbon dioxide
- dioxide gas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000314 lubricant Substances 0.000 title claims abstract description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 22
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229920002401 polyacrylamide Polymers 0.000 claims abstract description 13
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 10
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- 229940046009 vitamin E Drugs 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 9
- 239000003381 stabilizer Substances 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 claims description 4
- 239000011627 DL-alpha-tocopherol Substances 0.000 claims description 4
- 238000005187 foaming Methods 0.000 claims description 4
- 229960000984 tocofersolan Drugs 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 235000015110 jellies Nutrition 0.000 abstract description 7
- 239000008274 jelly Substances 0.000 abstract description 7
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 239000006260 foam Substances 0.000 abstract description 3
- 230000001050 lubricating effect Effects 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- -1 sucrose palmitic ester Chemical class 0.000 abstract description 2
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 210000001215 vagina Anatomy 0.000 abstract 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960003415 propylparaben Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 1
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、潤滑剤に関するもので
、更に詳しくは主として性交時の潤滑性及び腟の乾燥防
止をするムース状潤滑剤である。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a lubricant, and more particularly to a mousse-like lubricant that provides lubricity during sexual intercourse and prevents vaginal dryness.
【0002】0002
【従来の技術】従来、潤滑剤としては水溶性(液状)か
或いは半固体状(ゼリー状)のものであった。BACKGROUND OF THE INVENTION Conventionally, lubricants have been water-soluble (liquid) or semi-solid (jelly).
【0003】0003
【解決しようとする課題】したがって容器やチューブに
充填されており、使用に際して必要量以上の取出しが多
く塗布量が多くなると共に、その塗布も直接、塗布する
ことが出来ず、取り出す手と受け取る手との両手を使用
しなければならず、その受け取った側の手で塗布しなけ
ればならなかった。[Problem to be solved] Therefore, since it is filled in a container or tube, it is often necessary to take out more than the necessary amount when using it, resulting in a large amount of application. Both hands had to be used, and the receiving hand had to be used to apply.
【0004】本発明はこのような事情に鑑みなされたも
ので、見掛け状の量は多くなるが実際には少量でその効
果が得られかつ手で受け取ることなく、直接塗布出来る
ものを提供せんとするものである。[0004] The present invention was made in view of the above circumstances, and it is an object of the present invention to provide a product that can be applied directly without having to receive it by hand, and which can obtain the effect with a small amount, although the apparent amount is large. It is something to do.
【0005】[0005]
【課題を解決する手段】本発明は上記課題を解決するた
めになされたものであり、その手段はポリアクリルアミ
ドを主成分とし、グリセリンおよびビタミンE(dl−
α−トコフェロール)、起泡安定剤を添加し炭酸ガスと
混合してムース状としたものである。[Means for Solving the Problems] The present invention has been made to solve the above problems, and the means thereof consists of polyacrylamide as a main component, glycerin and vitamin E (dl-
α-tocopherol), a foaming stabilizer are added and mixed with carbon dioxide gas to form a mousse.
【0006】[0006]
【作用】ポリアクリルアミドを使用することにより、い
っそう潤滑性を増し、グリセリンにより、潤滑剤の保湿
性を増し、皮膚に対しても湿潤作用がある。又、ビタミ
ンE(dl−α−トコフェロール)によって酸化防止効
果とともに生殖腺に対する賦活作用及び人体粘膜の保護
作用がある。さらに、炭酸ガスと混合するためムース状
となる。[Action] The use of polyacrylamide further increases the lubricity, and the glycerin increases the moisturizing properties of the lubricant, which also has a moisturizing effect on the skin. In addition, vitamin E (dl-α-tocopherol) has an antioxidant effect, an activating effect on the gonads, and a protective effect on the human mucous membrane. Furthermore, since it mixes with carbon dioxide gas, it becomes mousse-like.
【0007】[0007]
【実施例】本発明の実施の一例について説明すると、防
腐剤としての作用をもつ粉状のメチルパラベンおよび粒
状をこまかく粉状につぶしたプロピルパラベンとビタミ
ンE、起泡安定剤としての界面活性剤とを溶解せしめた
グリセリンを、水にポリアクリルアミドを加えながら撹
拌して溶解させたものに混合撹拌する。[Example] To explain an example of the implementation of the present invention, powdered methylparaben that acts as a preservative, propylparaben that is finely crushed into powder, vitamin E, and a surfactant as a foaming stabilizer. Glycerin dissolved in polyacrylamide is mixed and stirred into water by stirring and dissolving polyacrylamide.
【0008】水は精製水を用いポリアクリルアミドを溶
解及び稀釈するためのものであり水分量は全体の80〜
98%で主成分となる。[0008] Purified water is used to dissolve and dilute the polyacrylamide, and the water content is 80 to 80% of the total water content.
It is the main component at 98%.
【0009】ポリアクリルアミドはアクリルアミド(モ
ノマー)を原料とするノニオン系の高分子凝集剤であり
、溶液粘度はその濃度を変えることにより、変化させる
ことが出来、 0.5〜 5.0%程度を添加する。[0009] Polyacrylamide is a nonionic polymer flocculant made from acrylamide (monomer), and the solution viscosity can be changed by changing its concentration, about 0.5 to 5.0%. Added.
【0010】グリセリンは比種の技術分野で周知のもの
であり、 1.0〜10%添加し、防腐剤としてメチル
パラベン0.05〜 0.375%,プロピルパラベン
0.01〜 0.125%、酸化防止及び粘膜保護とし
てビタミンE0.01〜0.10%を添加せしめる。[0010] Glycerin is well known in the technical field, and is added in an amount of 1.0 to 10%, and as preservatives, methylparaben is added at 0.05 to 0.375%, propylparaben is added at 0.01 to 0.125%, Vitamin E 0.01-0.10% is added to prevent oxidation and protect mucous membranes.
【0011】界面活性剤は起泡安定剤として添加するも
ので、例えば食品添加物として用いられているショ糖パ
ルミチン酸エステルを0.01〜1.00%添加する。The surfactant is added as a foaming stabilizer, and for example, 0.01 to 1.00% of sucrose palmitate, which is used as a food additive, is added.
【0012】これらの混合物を攪拌することによって粘
度 150〜1000好ましくは 200〜 500c
psのゼリー剤として容器内に充填し、内部圧力が5〜
8Kg/cm2 35℃で炭酸ガスを注入して混合する
。[0012] By stirring these mixtures, the viscosity becomes 150 to 1000 c, preferably 200 to 500 c.
It is filled into a container as a ps jelly, and the internal pressure is 5~5.
8Kg/cm2 Inject carbon dioxide gas at 35°C and mix.
【0013】ゼリー剤と炭酸ガスとの混合率は容量比で
50〜70%対50〜30%である。[0013] The mixing ratio of the jelly agent and carbon dioxide gas is 50 to 70% to 50 to 30% by volume.
【0014】次に具体的実施の態様を示すと、精製水
95.78ポリアクリルアミド ※1)
1.00グリセリン
3.00メチルパラベン
0.075プロピルパラベ
ン 0.025ビタ
ミンE(dl−α 0.
02−トコフェロール
P−1670 ※2)
0.01※1)三井サイアナミッド(株)製アコ
フロック N−100 SL
※2)ショ糖パルミチン酸エステル(食品添加物)[0014] Next, to show a specific embodiment, purified water
95.78 Polyacrylamide *1)
1.00 glycerin
3.00 Methylparaben
0.075 Propylparaben 0.025 Vitamin E (dl-α 0.025
02-Tocopherol P-1670 *2)
0.01 *1) Acofloc N-100 SL manufactured by Mitsui Cyanamid Co., Ltd. *2) Sucrose palmitate ester (food additive)
【0
015】先ず精製水に少しづつポリアクリルアミドを加
えながら20〜30分撹拌し溶解せしめる。次に、65
〜70℃の浴槽にひたしたグリセリンに、粒状のプロピ
ルパラベンをこまかく粉状につぶしたものと、粉状のメ
チルパラベンを少しづつ加えながら約20分攪拌し、次
にビタミンEとP−1670を加え約20分撹拌する。
これを先のポリアクリルアミドが溶解せる精製水に少し
づつ加えながら混合撹拌する。撹拌時に気泡が出るため
1晩常温で放置する。無色透明な粘度が 200〜 9
00cps(ブルックフィールド型粘土計No2ロータ
ー30、r.p.m30℃、pHが 7.5のゼリー状
であった。0
First, polyacrylamide is added little by little to purified water and stirred for 20 to 30 minutes to dissolve it. Next, 65
Add finely crushed granular propylparaben and powdered methylparaben little by little to glycerin soaked in a bath at ~70°C and stir for about 20 minutes, then add vitamin E and P-1670. Stir for approximately 20 minutes. This is added little by little to the purified water in which the polyacrylamide can be dissolved while stirring. Because air bubbles appear when stirring, leave it at room temperature overnight. Colorless and transparent with a viscosity of 200 to 9
00 cps (Brookfield clay meter No. 2 rotor 30, rpm 30°C, pH 7.5, jelly-like).
【0016】このゼリーを容器(缶)内へ充填し缶内圧
力5.6Kg /cm2 35℃となるように炭酸ガス
(CO2 )を注入した。[0016] This jelly was filled into a container (can), and carbon dioxide gas (CO2) was injected so that the pressure inside the can was 5.6 kg/cm2 and 35°C.
【0017】混合率は容量比でゼリー剤が60%,CO
2 が40%であった。[0017] The mixing ratio is 60% jelly by volume, CO
2 was 40%.
【表1】[Table 1]
【0018】[0018]
【効果】本発明は、ポリアクリルアミドを使用し、ねば
りを増すと共に、グリセリンにより湿潤性を高め、より
、すぐれた潤滑効果を示す。又、ビタミンE(dl−α
−トコフェロール)により生殖線作用を賦活させ人体粘
膜を保護する作用があり、経時変化も少なく、しかも臭
いや毒性など無いため皮膚を刺激することもなく安定で
あり、老化防止効果を有し潤滑剤としてすぐれたものを
提供することが出来る。[Effect] The present invention uses polyacrylamide to increase stickiness, and glycerin to improve wettability, thereby exhibiting a more excellent lubricating effect. In addition, vitamin E (dl-α
-Tocopherol) has the effect of activating reproductive rays and protecting human mucous membranes, has little change over time, has no odor or toxicity, is stable without irritating the skin, has anti-aging effects, and is a lubricant. We can provide you with excellent products.
【0019】又、炭酸ガスを使用することによってLP
Gと比較して、使用に際し、粘膜への刺激性も無く、消
泡が早い為、引火への安全性も高いものである。[0019] Furthermore, by using carbon dioxide gas, LP
Compared to G, it is less irritating to mucous membranes when used, defoams quickly, and is highly safe against ignition.
【0020】更に粘度があるため塗布量がコントロール
出来、必要量以上の塗布を防止し得て経済性もある。こ
の点、従来の液体、半固体状のものは塗布量が多くなる
傾向があるが、本発明の場合には細かく発泡している為
、見掛状の量は多くなるが実際には少量で潤滑効果が得
られる。Furthermore, because of its viscosity, it is possible to control the amount of application and prevent application of more than the required amount, which is also economical. In this regard, conventional liquid and semi-solid products tend to require a large amount of application, but in the case of the present invention, the amount of foam applied is fine, so although the apparent amount is large, it is actually a small amount. Provides a lubricating effect.
【0021】しかも、従来は一度、人差指など手に取り
出して要部に塗布していたが、本発明の場合には直接要
部に塗布できる為、非常に衛生的で、スピーディーに使
用し得ると共にその塗布も両手を使うことなく片手で処
理できるものであり、分泌液の少ない人やタンポン等に
も可能で補助的使用も可能であり、有益なものである。Moreover, in the past, it was once applied to the main parts of the hand such as the index finger, but in the case of the present invention, it can be applied directly to the main parts, so it is very hygienic and can be used quickly. The application can be done with one hand without using both hands, and it is also useful for people who have little secretion, tampons, etc., and can also be used as a supplement.
Claims (1)
リセリン及びビタミンE(dl−α−トコフェロール)
、起泡安定剤を添加し炭酸ガスと混合してなるムース状
潤滑剤。[Claim 1] Polyacrylamide as the main component, glycerin and vitamin E (dl-α-tocopherol)
, a mousse-like lubricant made by adding a foaming stabilizer and mixing it with carbon dioxide gas.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7912091A JP3100416B2 (en) | 1991-04-11 | 1991-04-11 | Moose-like lubricant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7912091A JP3100416B2 (en) | 1991-04-11 | 1991-04-11 | Moose-like lubricant |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04312521A true JPH04312521A (en) | 1992-11-04 |
JP3100416B2 JP3100416B2 (en) | 2000-10-16 |
Family
ID=13681068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7912091A Expired - Lifetime JP3100416B2 (en) | 1991-04-11 | 1991-04-11 | Moose-like lubricant |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3100416B2 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689339B1 (en) | 1997-11-07 | 2004-02-10 | Medion Research Laboratories Inc. | Viscous compositions containing carbon dioxide |
GB2416992A (en) * | 2004-08-13 | 2006-02-15 | Britannia Medicare Ltd | Personal lubricant |
US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
-
1991
- 1991-04-11 JP JP7912091A patent/JP3100416B2/en not_active Expired - Lifetime
Cited By (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689339B1 (en) | 1997-11-07 | 2004-02-10 | Medion Research Laboratories Inc. | Viscous compositions containing carbon dioxide |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US11033491B2 (en) | 2002-10-25 | 2021-06-15 | Vyne Therapeutics Inc. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
GB2416992A (en) * | 2004-08-13 | 2006-02-15 | Britannia Medicare Ltd | Personal lubricant |
US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US11103454B2 (en) | 2007-08-07 | 2021-08-31 | Vyne Therapeutics Inc. | Wax foamable vehicle and pharmaceutical compositions thereof |
US10369102B2 (en) | 2007-08-07 | 2019-08-06 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
US11433025B2 (en) | 2007-12-07 | 2022-09-06 | Vyne Therapeutics Inc. | Oil foamable carriers and formulations |
US10213384B2 (en) | 2009-04-28 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10588858B2 (en) | 2009-04-28 | 2020-03-17 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10363216B2 (en) | 2009-04-28 | 2019-07-30 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
US11219631B2 (en) | 2009-07-29 | 2022-01-11 | Vyne Pharmaceuticals Inc. | Foamable compositions, breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US10821187B2 (en) | 2009-10-02 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US10265404B2 (en) | 2009-10-02 | 2019-04-23 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10463742B2 (en) | 2009-10-02 | 2019-11-05 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10517882B2 (en) | 2009-10-02 | 2019-12-31 | Foamix Pharmaceuticals Ltd. | Method for healing of an infected acne lesion without scarring |
US10238746B2 (en) | 2009-10-02 | 2019-03-26 | Foamix Pharmaceuticals Ltd | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10610599B2 (en) | 2009-10-02 | 2020-04-07 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10213512B2 (en) | 2009-10-02 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10322186B2 (en) | 2009-10-02 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10835613B2 (en) | 2009-10-02 | 2020-11-17 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
US10946101B2 (en) | 2009-10-02 | 2021-03-16 | Vyne Therapeutics Inc. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10967063B2 (en) | 2009-10-02 | 2021-04-06 | Vyne Therapeutics Inc. | Surfactant-free, water-free formable composition and breakable foams and their uses |
US10137200B2 (en) | 2009-10-02 | 2018-11-27 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10086080B2 (en) | 2009-10-02 | 2018-10-02 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10849847B2 (en) | 2016-09-08 | 2020-12-01 | Foamix Pharamaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US11324691B2 (en) | 2016-09-08 | 2022-05-10 | Journey Medical Corporation | Compositions and methods for treating rosacea and acne |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Also Published As
Publication number | Publication date |
---|---|
JP3100416B2 (en) | 2000-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04312521A (en) | Mousse-like lubricant | |
KR950700072A (en) | Composi-tions of clindamycin and benzoyl peroxide for acne treatment containing clindamycin and benzoyl peroxide | |
ATE151982T1 (en) | FOAMABLE AGENT FOR PHARMACEUTICAL USE, THEREOF USE AND TREATMENT METHOD | |
WO1999025310A1 (en) | Water-in-oil emulsifier composition | |
GB2076286A (en) | Dermatological hydrogen peroxide compositions | |
JPH05213734A (en) | Aerosol massage agent | |
JP5723104B2 (en) | Emulsion composition for skin | |
JPH06219923A (en) | Transparent liquid composition | |
KR20100133111A (en) | Stable inverse emulsion | |
JPS6241645B2 (en) | ||
KR102317099B1 (en) | Cosmetic composition designed for breaking up algin capsule using chelating effect polymer | |
JP6726498B2 (en) | External composition | |
JP2004143064A (en) | Bleaching composition | |
CN108158851B (en) | Water-soluble squalane composition, preparation method and application thereof, and cosmetic using water-soluble squalane composition | |
JPS585883B2 (en) | Pine surgery composition | |
JPH05294825A (en) | Lubricant | |
KR20150058935A (en) | Cosmetic composition containing oil-in-water type | |
KR930010579B1 (en) | Antifungus gel preparation | |
JPH0334919A (en) | Bathing agent | |
JP2012111722A (en) | Skin pretreatment agent | |
JP2022096993A (en) | Pharmaceutical composition for external use | |
JP2022096992A (en) | Pharmaceutical composition for external use | |
JP4149285B2 (en) | Ceramide-containing gel composition | |
JPH04154726A (en) | Lubricant | |
JPH07285861A (en) | External preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080818 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090818 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090818 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100818 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110818 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110818 Year of fee payment: 11 |